Trial intelligence / Profile preview

Comparison of Remifentanil and Dexmedetomidine for MAC in Vertebroplasty and Kyphoplasty

NCT02476981Completed

Sponsor
Hallym University Medical Center
Start
Aug 2012
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in Vertebral compression fracture (VCF) (2 arms), sponsored by Hallym University Medical Center. Primary endpoint: Frequency of oxygen desaturation. Started Aug 2012; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Vertebral compression fracture (VCF)

Beyond the preview

Go deeper on NCT02476981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02476981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call